Crossmark

Adjuvant Chemotherapy versus Concurrent Chemoradiotherapy for Surgically Treated T1b Uterine Cervical Cancer: A Propensity Score Matched Analysis of the JSOG Nationwide Data

Crossref DOI link: https://doi.org/10.1245/s10434-024-16638-2

Published Online: 2024-12-11

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanaka, Yusuke

Higami, Shota

Ishii, Tomomi

Shiki, Yasuhiko

Ueda, Yutaka

Kimura, Tadashi
License Information

Text and Data Mining valid from 2024-12-11

Version of Record valid from 2024-12-11
More Information

Article History

Received: 10 September 2024

Accepted: 20 November 2024

First Online: 11 December 2024

Disclosure

: Yusuke Tanaka, Shota Higami, Tomomi Ishii, Yasuhiko Shiki, Yutaka Ueda, and Tadashi Kimura declare they have no conflicts of interest that may be relevant to the contents of this study.

Document is current

Any future updates will be listed below